Titre : BIOVECTRA OVERVIEW AND FLOW COLLABORATION
Résumé de la presentation:
BioVectra is a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Synthetic small molecules, fermented small molecules, highly potent APIs, biologics, bioreagents.
Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We assure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.
Biographie du conférencier:
Dr. Vincent-Rocan obtained his B.Sc (2011) and Ph.D (2016) from University of Ottawa under the supervision of Andre Beauchemin (nitrogen substituted isocyanates a new tool for heterocyclic chemistry). He then began his career at Paraza Pharma as a Research Scientist from 2016 to 2018. He lead chemical development projects for small biotech and large pharma. He then joined BioVectra in 2018 as a Senior Scientist/Group leader. He manages a group of chemists and projects from pre-clinical batches to commercial manufacturing. Since 2021, he has been promoted to Business development manager for small molecules portfolio including managing their growing flow chemistry capabilities
